Description
CABOZANIX 60mg Tablets (Cabozantinib) – 30’s
CABOZANIX 60mg is a prescription oral cancer medication containing cabozantinib, a targeted therapy used for the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer) in patients previously treated with sorafenib, and radioactive iodine-refractory differentiated thyroid cancer. As a tyrosine kinase inhibitor, CABOZANIX works by blocking key pathways that promote tumor growth, angiogenesis, and cancer cell survival.
Each pack contains 30 film-coated tablets, formulated for once-daily dosing on an empty stomach. CABOZANIX is clinically proven to help slow disease progression and extend survival in eligible patients. Common side effects may include fatigue, high blood pressure, diarrhea, weight loss, and mouth sores.
Key Features:
-
Contains cabozantinib 60mg per tablet
-
Treats advanced kidney, liver, and thyroid cancers
-
Pack of 30 tablets for a full month’s course
-
Taken once daily on an empty stomach
-
Should be used under medical supervision
Ideal for oncologists and patients seeking an effective targeted therapy option for aggressive or treatment-resistant cancers.
